OSA logo

ProSomnus (OSA)

Profile

Full Name

ProSomnus, Inc.

Ticker Symbol

OSA

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

July 28, 2021

Indexes

Not included

Website

http://www.prosomnus.com

Employees

136

Key Details

Price

$0.47

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$27.65M(+42.59% YoY)

Annual EPS

-$1.49(-109.86% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.47
OSA price is $0.47

30-Day Relative Volume

2.75
OSA 30-day relative volume is 2.75

Price Performance

Price Most recent change

-
OSA price change on Apr 1, 2025 is unknown

Price YTD change

-
OSA price ytd change is unknown

Price 1-year change

-16.96%
OSA price is down -16.96% year-on-year

Price 3-year change

-
OSA price 3-year change is unknown

Price Range

Price All-time high

$9.41
OSA price is currently -95.01% below its historical high of $9.41

Price 3-year low

$0.00
OSA price is currently >+9900.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$8.18M
OSA market capitalization is $8.18 million

Market cap 3-year change

-
OSA market capitalization 3-year change is unknown

Market cap All-time high

$109.13M
OSA market capitalization is currently -92.51% below its historical high of $109.13 million

Market cap sector rank

17.42%
OSA market capitalization is higher than 17.42% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
OSA {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

-
OSA shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-39.98
OSA beta is -39.98

200-day SMA

$0.43
OSA price is currently +9.81% above its 200-day simple moving average

50-day SMA

$0.05
OSA price is currently +855.28% above its 50-day simple moving average

RSI

97.45
OSA 14-day relative strength index is 97.45

Volume

2.75
OSA 30-day relative volume is 2.75

ATR

$0.02
OSA average true range is $0.02

10-day Historical Volatility

16.79K%
OSA 10-day historical volatility is 16.79 thousand%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$27.65M
OSA annual revenue is $27.65 million

Revenue Analysts estimate

$34.19M
OSA annual revenue is currently -19.12% lower than the consensus analysts' forecast

Revenue 1-year change

+42.59%
OSA annual revenue is up +42.59% year-on-year

Revenue Sector rank

37.85%
OSA annual revenue is higher than 37.85% of companies in Healthcare sector

EPS

EPS

-$1.49
OSA annual earnings per share is -$1.49

EPS Analysts estimate

-$1.10
OSA annual earnings per share is currently +35.45% higher than the consensus analysts' forecast

EPS 1-year change

-109.86%
OSA annual earnings per share is down -109.86% year-on-year

EPS Sector rank

45.91%
OSA annual earnings per share is higher than 45.91% of companies in Healthcare sector

Profit

Gross profit

$14.01M
OSA annual gross profit is $14.01 million

Gross margin

50.67%
OSA annual gross profit margin is 50.67%

Operating profit

-$19.11M
OSA annual operating income is -$19.11 million

Operating margin

-69.09%
OSA annual operating profit margin is -69.09%

Net income

-$24.09M
OSA annual net profit is -$24.09 million

Net margin

-87.14%
OSA annual net profit margin is -87.14%

Expenses

Total expenses

$46.76M
OSA annual total expenses is $46.76 million

Operating expenses

$33.12M
OSA annual total operating expenses is $33.12 million

Cost of goods sold

$13.64M
OSA annual cost of goods sold is $13.64 million

Selling, general & administrative expenses

$28.32M
OSA annual SGA is $28.32 million

Depreciation and amortization

$978.00K
OSA annual depreciation & amortization is $978.00 thousand

Interest expense

$5.38M
OSA annual interest expense is $5.38 million

Income tax

-
OSA annual income tax value is unknown

EBIT & EBITDA

EBIT

-$18.71M
OSA annual earnings before interest & taxes is -$18.71 million

EBITDA

-$17.73M
OSA annual EBITDA is -$17.73 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$26.29M
OSA annual total assets is $26.29 million

Non current assets

$11.98M
OSA annual long term assets is $11.98 million

Current assets

$14.31M
OSA annual total current assets is $14.31 million

Cash and cash equivalents

$6.36M
OSA annual cash & cash equivalents is $6.36 million

Accounts receivable

$3.84M
OSA annual accounts receivable is $3.84 million

Inventory

$2.04M
OSA annual inventory is $2.04 million

Liabilities

Total liabilities

$64.44M
OSA annual total liabilities is $64.44 million

Long term liabilities

$50.10M
OSA annual total long term liabilities is $50.10 million

Current liabilities

$14.34M
OSA annual total current liabilities is $14.34 million

Accounts payable

$4.05M
OSA annual accounts payable is $4.05 million

Debt

Total debt

$41.37M
OSA annual total debt is $41.37 million

Total debt 1-year change

+25.05%
OSA annual total debt is up +25.05% year-on-year

Long term debt

$37.83M
OSA annual long term debt is $37.83 million

Short term debt

$3.54M
OSA annual short term debt is $3.54 million

Equity & Capital

Shareholders equity

-$38.16M
OSA annual stockholders equity is -$38.16 million

Book value

-$38.16M
OSA annual book value is -$38.16 million

Retained earnings

-$234.89M
OSA annual retained earnings is -$234.89 million

Working capital

-$31.00K
OSA annual working capital is -$31.00 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$16.13M
OSA annual cash flow from operations is -$16.13 million

Cash from operations 1-year change

-57.51%
OSA annual cash flow from operations is down -57.51% year-on-year

Cash from investing

-$1.47M
OSA annual cash flow from investing activities is -$1.47 million

Cash from investing 1-year change

-8.35%
OSA annual cash flow from investing activities is down -8.35% year-on-year

Cash from financing

$8.74M
OSA annual cash flow from financing activities is $8.74 million

Cash from financing 1-year change

-66.39%
OSA annual cash flow from financing activities is down -66.39% year-on-year

CAPEX

CAPEX

$1.47M
OSA annual capital expenditures is $1.47 million

CAPEX 1-year change

+8.35%
OSA annual capital expenditures is up +8.35% year-on-year

Free Cash Flow

Free cash flow

-$17.59M
OSA annual free cash flow is -$17.59 million

Free cash flow 1-year change

-51.76%
OSA annual free cash flow is down -51.76% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

50.67%
OSA annual gross profit margin is 50.67%

Operating margin

-69.09%
OSA annual operating profit margin is -69.09%

Net margin

-87.14%
OSA annual net profit margin is -87.14%

ROA & ROE

ROA

-81.01%
OSA annual return on assets is -81.01%

ROE

63.15%
OSA annual return on equity is 63.15%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OSA price to earnings ratio value is unknown

PE ratio Sector rank

-
OSA price to earnings ratio is unknown

PB Ratio

PB ratio

-0.17
OSA price to book ratio is -0.17

PB ratio Sector rank

12.42%
OSA price to book ratio is higher than 12.42% of companies in Healthcare sector

PS Ratio

PS ratio

0.26
OSA price to sales ratio is 0.26

PS ratio Sector rank

9.1%
OSA price to sales ratio is higher than 9.1% of companies in Healthcare sector

Enterprise value

Enterprise value

$24.07M
OSA enterprise value is $24.07 million

Enterprise value Sector rank

34.19%
OSA enterprise value is higher than 34.19% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.25
OSA EV/EBITDA is -2.25

EV/EBITDA Sector rank

29.11%
OSA EV/EBITDA is higher than 29.11% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.00
OSA annual current ratio is 1.00

Quick ratio

0.86
OSA annual quick ratio is 0.86

Leverage

Debt to equity

-0.86
OSA annual debt to equity ratio is -0.86

Interest coverage ratio

-3.48
OSA annual interest coverage ratio is -3.48

Risk & Stability

Piotroski F-Score

3
OSA piotroski f-score is 3

Altman Z-Score

-13.73
OSA altman z-score is -13.73

Analyst ratings

Recent major analysts updates

Jan 22, 24 Alliance Global Partners
Buy
Nov 10, 23 Craig-Hallum
Hold
Sep 26, 23 Roth MKM
Buy
Apr 18, 23 Roth MKM
Buy
Apr 3, 23 Craig-Hallum
Buy

Institutional Ownership

Similar stocks

NXTC logo
NextCure (NXTC)
MGRX logo
Mangoceuticals (MGRX)
CTXR logo
Citius Pharmaceuticals (CTXR)
PHIO logo
Phio Pharmaceuticals (PHIO)
MHUA logo
Meihua International Medical Technologies Co (MHUA)
KPRX logo
Kiora Pharmaceuticals (KPRX)
PRPO logo
Precipio (PRPO)
APRE logo
Aprea Therapeutics (APRE)
PMCB logo
PharmaCyte Biotech (PMCB)
  • What is the ticker symbol for ProSomnus?
  • Does ProSomnus pay dividends?
  • What sector is ProSomnus in?
  • What industry is ProSomnus in?
  • What country is ProSomnus based in?
  • When did ProSomnus go public?
  • Is ProSomnus in the S&P 500?
  • Is ProSomnus in the NASDAQ 100?
  • Is ProSomnus in the Dow Jones?
  • When was ProSomnus's last earnings report?
  • When does ProSomnus report earnings?
  • Should I buy ProSomnus stock now?

What is the ticker symbol for ProSomnus?

The ticker symbol for ProSomnus is NASDAQ:OSA

Does ProSomnus pay dividends?

No, ProSomnus does not pay dividends

What sector is ProSomnus in?

ProSomnus is in the Healthcare sector

What industry is ProSomnus in?

ProSomnus is in the Medical Devices industry

What country is ProSomnus based in?

ProSomnus is headquartered in United States

When did ProSomnus go public?

ProSomnus's initial public offering (IPO) was on July 28, 2021

Is ProSomnus in the S&P 500?

No, ProSomnus is not included in the S&P 500 index

Is ProSomnus in the NASDAQ 100?

No, ProSomnus is not included in the NASDAQ 100 index

Is ProSomnus in the Dow Jones?

No, ProSomnus is not included in the Dow Jones index

When was ProSomnus's last earnings report?

ProSomnus's most recent earnings report was on Nov 14, 2024

When does ProSomnus report earnings?

The date for ProSomnus's next earnings report has not been announced yet

Should I buy ProSomnus stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page